Yeonguk Jeon

Title: Yeonguk Jeon: Innovator in Biotherapeutics

Introduction

Yeonguk Jeon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotherapeutics, holding a total of 3 patents. His work focuses on developing innovative compounds that address various medical disorders.

Latest Patents

One of Yeonguk Jeon's latest patents is for substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors. This patent provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, along with a composition comprising the compound. It also outlines methods of using the compound for the treatment of various disorders associated with HPK1, as well as methods for preparing these compounds. Another notable patent involves 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds. This patent details a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, and a pharmaceutical composition comprising the compound. It also describes a method for treating or preventing inflammatory and autoimmune diseases, particularly neuroinflammation diseases, using the compound.

Career Highlights

Yeonguk Jeon is currently associated with 1st Biotherapeutics, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the biotherapeutics industry.

Collaborations

Yeonguk Jeon collaborates with talented individuals such as Jinhwa Lee and Suyeon Jo, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yeonguk Jeon is a dedicated inventor whose work in biotherapeutics is paving the way for new treatments and therapies. His patents reflect his commitment to addressing critical health challenges through innovative solutions.